La FFR es un nuevo modelo matemático que podría ser útil en el ámbito médico para calcular la aterosclerosis estenótica de las arterias coronarias . La medida de fiabilidad (fácilmente reproducible) entre laboratorios que compiten para probar esta métrica crucial todavía está en disputa en una carrera por la propiedad que afirma la matemática cardíaca basada en el riesgo para la enfermedad cardíaca isquémica.
El flujo sanguíneo a una parte específica del cuerpo se mide mediante un procedimiento de reserva de flujo fraccional. Los pacientes reciben una inyección de material radiactivo antes del procedimiento, que se utilizará para obtener imágenes del flujo sanguíneo en una zona específica del cuerpo. Después de obtener las imágenes, se realiza una pequeña incisión, se mide el flujo sanguíneo y se administra anestesia local.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (millones de USD) |
| Segmentación | Por tipo, por tecnología, por aplicación, por región. |
| Por tipo |
|
| Por tecnología |
|
| Por aplicación |
|
| Por región |
|
Se está incrementando el gasto en investigación y desarrollo (I+D) para crear equipos novedosos que sean rentables y eficientes a medida que aumentan los casos de enfermedades cardiovasculares, como la hipertensión arterial y las enfermedades de las arterias coronarias. Según la OMS, 17,9 millones de personas murieron por enfermedades cardiovasculares en 2021, es decir, aproximadamente el 31% de todas las muertes en todo el mundo.
La reserva de flujo fraccional es un procedimiento no invasivo que se utiliza para evaluar la enfermedad de las arterias coronarias (EAC) en pacientes con estenosis de las arterias coronarias. La prueba de reserva de flujo fraccional es un análisis de sangre que mide la presión arterial.
Se espera que la creciente población geriátrica aumente la demanda de reserva de flujo fraccional. Las personas mayores de 65 años son más vulnerables a las enfermedades cardiovasculares y crónicas como la diabetes. La diabetes tipo II también puede provocar la formación de células grasas en la arteria coronaria, lo que puede causar un bloqueo y, como resultado, un derrame cerebral o un ataque cardíaco. Debido a la aparición tardía de baby boomers en países como Japón, China y Brasil, entre otros, se espera que la población geriátrica mundial crezca exponencialmente en los próximos años. Las Naciones Unidas estimaron que la población de personas de 65 años o más era de 703 millones en 2019, y se espera que la cifra se duplique hasta alcanzar los 1.500 millones en 2050.
La reducción de los servicios y procedimientos cardiovasculares a causa de la pandemia de COVID-19 tuvo un impacto considerable en la expansión del mercado. Sin embargo, se recomendó que los pacientes cardiovasculares continuaran con su terapia FFR para aumentar sus posibilidades de supervivencia y controlar mejor la capacidad de su sistema inmunológico para defenderse del virus SARS-CoV-2. Según el análisis, estos sucesos ayudaron al mercado a crecer durante la pandemia y se prevé que lo hagan nuevamente en los próximos años.
Una evaluación de la FFR no puede distinguir entre enfermedad de las arterias coronarias, espasmo de las arterias coronarias o estenosis coronaria. La capacidad de una evaluación para verse influenciada por elementos externos como la presión arterial y la frecuencia cardíaca es otro inconveniente. Además, la medición podría necesitar ser más precisa para determinadas personas o pacientes con enfermedad de las arterias coronarias. La prueba también es costosa, invasiva y solo apropiada para algunos pacientes.
The fractional flow reserve market reached USD 671.40 million in 2020 and is expected to grow at a CAGR of more than 11.2% through 2029, owing to the increasing in awareness about health.
The upcoming trend in the fractional flow reserve market is an opportunity for market growth.
The global fractional flow reserve market registered a CAGR of 11.2% from 2022 to 2029.
Key players profiled in the report include OPSENS Medical, Abbott Laboratories, Koninklijke Philips N.V., Acist Medical Systems Inc., Boston Scientific, Medtronic plc, B. Braun Melsungen, Siemens, Terumo Medical Corporation and Medis Medical Imaging System.
The North America fractional flow reserve market had largest market share of 37% in 2021. The dominance of the region can be attributed to favorable government policies for medical device penetration and the presence of well-developed healthcare infrastructure. In addition, rising mergers and acquisitions by key players are poised to keep the level of competition high in the near future.
The introduction of technologically advanced monitoring systems is expected to drive profitable growth in the FFR monitoring systems segment during the forecast period. Due to their widespread use in diagnostic cardiovascular procedures, FFR guidewires held a commanding 58.06% market share in 2021. This segment is expected to grow at a healthy CAGR during the forecast period due to increased use for coronary artery disease diagnosis globally. According to the Centers for Disease Control and Prevention (CDC), approximately 360,900 people died in the United States in 2019 as a result of coronary artery disease. Furthermore, the elderly is more vulnerable to cardiac problems. As a result, the segment's growth is aided by the segment's expanding base.
Technology-based categories for invasive and non-invasive monitoring make up the fractional flow reserve market. In 2021, the non-invasive segment held the largest market share in the fractional flow reserve market due to the low risk of procedural complications and the availability of clinical evidence demonstrating its efficacy. For assessing the hemodynamic effects of coronary lesions, invasive FFR monitoring is regarded as the gold standard. For the purpose of measuring fractional flow reserve, this technology makes use of pressure guidewires and monitoring systems. The blood flow and pressure before and after the blockage are measured by the pressure guidewire to create a ratio.
Invasive fractional flow reserve systems are widely used to assess lesion-specific ischemic in patients with 50% to 90% stenosis. The invasive segment has made only modest progress. One of the main causes of the slower adoption of non-invasive FFR systems is that many clinicians continue to think that angiography yields superior results and that this will be sufficient to determine the patients' treatment course. The diagnostic procedures are also left up to the discretion of the local practitioners, though many still favour CT scans, nuclear tests, and invasive angiography.
As a more advanced form of single-vessel CAD, the multi-vessel coronary artery disease (CAD) segment is anticipated to register a higher CAGR during the forecast period. If proper care and medication are not taken, a person with single-vessel CAD is very likely to develop multi-vessel CAD in the near future. Due to the widespread use of the device in CAD and the growing elderly population, the single-vessel coronary artery disease (CAD) segment dominated the fractional flow reserve market in 2021 with a share of over 50.04%.
[caption id="attachment_23491" align="aligncenter" width="1920"]
Key players involved in fractional flow reserve market are OPSENS Medical, Abbott Laboratories, Koninklijke, Philips N.V., Acist Medical Systems Inc., Boston Scientific, Medtronic plc, B. Braun Melsungen, Siemens, Terumo Medical Corporation and Medis Medical Imaging System. Mergers and acquisitions, joint ventures, capacity expansions, significant distribution, and branding decisions by established industry players to boost market share and regional presence. They are also engaged in continuous R&D activities to develop new Product Products and are focused on expanding the Product type portfolio. This is expected to increase competition and pose a threat to new market entrants.
Geographically, the Fractional Flow Reserve market is segmented into North America, South America, Europe, APAC and MEA.
Due to the growing geriatric population linked to cardiovascular diseases and the growing technological advancements in FFR monitoring devices, North America is anticipated to hold a significant market share in the fractional flow reserve market. The global fractional flow reserve market was dominated by the United States. The United States has become a major fractional flow reserve market shareholder due to the faster adoption of value-based products in the healthcare system, increased clinician awareness, and increasing adoption of FFR-CT.
The market for fractional flow reserves is anticipated to experience profitable growth in the Asia Pacific region over the next few years as a result of an increase in diabetes and cardiovascular disease cases as well as rising disposable income. Additionally, it is anticipated that the adoption of laws that are favorable to medical device adoption will support the expansion of the regional market.
Values-based and volume-based healthcare providers coexist in Europe's healthcare system. The value-based treatment providers adopt it more quickly. Some of the developing economies in Europe have a low rate of adoption of cutting-edge technologies. The usage of cutting-edge products and the growth of the non-invasive fractional flow reserve market are primarily driven by the rising number of CATH Labs and office-based labs.
The nations of Latin America are renowned as places to receive various medical treatments. Urban hospitals use a lot of cutting-edge technology to draw tourists. Due to a lack of reimbursement, local patients rarely use this service and instead choose to undergo more expensive market tests. Additionally, the market's reliance on traditional methods is constrained by a lack of trained lab technicians.
[caption id="attachment_23492" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.